Moreover, while neither of these biomarkers alone can predict AP-related bone resorption, when used together, GCF sclerostin and PGE-2 levels were shown to be effective in diagnosing bone resorption in AP and monitoring its progression. The gene discussed is SOST; the disease is alkaline phosphatase measurement.